Aptevo Therapeutics Inc. — Director's Dealing 2017

Mar 14, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Aptevo Therapeutics Inc. (APVO)
CIK: 0001671584
Period of Report: 2017-03-01

Reporting Person: Lamothe Jeffrey G. (SVP, CFO and Treasurer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-03-01	Common Stock	M	7320	—	Acquired	24386	Direct
2017-03-01	Common Stock	F	1936	$2.02	Disposed	22450	Direct
2017-03-01	Common Stock	M	6746	—	Acquired	29196	Direct
2017-03-10	Common Stock	F	1785	$1.78	Disposed	27411	Direct
2017-03-10	Common Stock	M	18863	—	Acquired	46274	Direct
2017-03-10	Common Stock	F	4990	$1.78	Disposed	41284	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-03-01	Restricted Stock Unit	$	M	7320	Disposed		Common Stock (7320)	Direct
2017-03-10	Restricted Stock Unit	$	M	6746	Disposed		Common Stock (6746)	Direct
2017-03-10	Restricted Stock Unit	$	M	18863	Disposed		Common Stock (18863)	Direct

Footnotes

F1: Each RSU converts into the Issuer's common stock on a one-for-one basis.

F2: The RSUs were originally issued by Emergent BioSolutions, Inc. ("Emergent") on March 1, 2016. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016 (the "Spin-off"), each RSU was adjusted and assumed by the Issuer. The RSUs vest as follows: 7,320 on March 1, 2017, 7,320 on March 1, 2018 and 7,318 on March 1, 2019.

F3: The RSUs were originally issued by Emergent on March 10, 2015 and, as a result of the Spin-off, were adjusted and assumed by the Issuer. The RSUs vest as follows: 6,746 on March 10, 2017 and 6,747 on March 10, 2018.

F4: The RSUs were originally issued by Emergent on March 11, 2014 and, as a result of the Spin-off, were adjusted and assumed by the Issuer. The RSUs fully vested on March 10, 2017.